Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS
Arnold, Douglas L., Fisher, Elizabeth, Brinar, Vesna V., Cohen, Jeffrey A., Coles, Alasdair J., Giovannoni, Gavin, Hartung, Hans-Peter, Havrdova, Eva, Selmaj, Krzysztof W., Stojanovic, Miroslav, WeineLanguage:
english
Journal:
Neurology
DOI:
10.1212/WNL.0000000000003169
Date:
September, 2016
File:
PDF, 725 KB
english, 2016